BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1380 related articles for article (PubMed ID: 9747827)

  • 21. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
    Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
    Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medial tumor localization in breast cancer--an unappreciated risk factor?
    Bräutigam E; Track C; Seewald DH; Feichtinger J; Spiegl K; Hammer J
    Strahlenther Onkol; 2009 Oct; 185(10):663-8. PubMed ID: 19806331
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local radiotherapy alone following neoadjuvant chemotherapy and surgery in combined clinical stage II and III breast cancer.
    White R; Dinneen T; Makris A
    Radiat Oncol; 2016 Jul; 11():93. PubMed ID: 27457764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alternative therapy for elderly patients with breast cancer.
    von Rueden DG; Sessions SC
    Am Surg; 1994 Jan; 60(1):72-8. PubMed ID: 8273979
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pattern of failure in patients with inflammatory breast cancer treated by alternating radiotherapy and chemotherapy.
    Thomas F; Arriagada R; Spielmann M; Mouriesse H; Le Chevalier T; Fontaine F; Tursz T
    Cancer; 1995 Dec; 76(11):2286-90. PubMed ID: 8635033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?
    Vujovic O; Perera F; Dar AR; Stitt L; Yu E; Voruganti SM; Truong PT
    Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):869-74. PubMed ID: 9531372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammographically detected ductal carcinoma in situ treated with conservative surgery with or without radiation therapy: patterns of failure and 10-year results.
    Kestin LL; Goldstein NS; Martinez AA; Rebner M; Balasubramaniam M; Frazier RC; Register JT; Pettinga J; Vicini FA
    Ann Surg; 2000 Feb; 231(2):235-45. PubMed ID: 10674616
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast conservation therapy for early stage breast carcinoma with outstanding 10-year locoregional control rates: a case for aggressive therapy to the tumor bearing quadrant.
    Schmidt-Ullrich RK; Wazer DE; DiPetrillo T; Marchant DJ; Smith TJ; Safaii H; Schmid C; Homer MJ
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):545-52. PubMed ID: 8226147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.
    Shah C; Wilkinson JB; Shaitelman S; Grills I; Wallace M; Mitchell C; Vicini F
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e547-51. PubMed ID: 21640491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.
    Cocquyt VF; Blondeel PN; Depypere HT; Praet MM; Schelfhout VR; Silva OE; Hurley J; Serreyn RF; Daems KK; Van Belle SJ
    Eur J Surg Oncol; 2003 May; 29(4):361-7. PubMed ID: 12711290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brachytherapy or electron beam boost in conservation therapy of carcinoma of the breast: a nonrandomized comparison.
    Perez CA; Taylor ME; Halverson K; Garcia D; Kuske RR; Lockett MA
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(5):995-1007. PubMed ID: 8600112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathologic response to short intensified taxane-free neoadjuvant chemotherapy in patients with highly proliferative operable breast cancer.
    Le Tourneau C; Dettwiler S; Beuzeboc P; Alran S; Laurence V; Pierga JY; Fréneaux P; Sigal-Zafrani B; Diéras V; Vincent-Salomon A
    Am J Clin Oncol; 2012 Jun; 35(3):242-6. PubMed ID: 21358298
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outcome of conservative therapy for invasive breast cancer by histologic subtype.
    Weiss MC; Fowble BL; Solin LJ; Yeh IT; Schultz DJ
    Int J Radiat Oncol Biol Phys; 1992; 23(5):941-7. PubMed ID: 1322387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Timing of radiotherapy and chemotherapy following breast-conserving surgery for patients with node-positive breast cancer. International Breast Cancer Study Group.
    Wallgren A; Bernier J; Gelber RD; Goldhirsch A; Roncadin M; Joseph D; Castiglione-Gertsch M
    Int J Radiat Oncol Biol Phys; 1996 Jul; 35(4):649-59. PubMed ID: 8690630
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with local recurrence of mammographically detected ductal carcinoma in situ in patients given breast-conserving therapy.
    Kestin LL; Goldstein NS; Lacerna MD; Balasubramaniam M; Martinez AA; Rebner M; Pettinga J; Frazier RC; Vicini FA
    Cancer; 2000 Feb; 88(3):596-607. PubMed ID: 10649253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Goserelin plus tamoxifen compared to chemotherapy followed by tamoxifen in premenopausal patients with early stage-, lymph node-negative breast cancer of luminal A subtype.
    Alramadhan M; Ryu JM; Rayzah M; Nam SJ; Kim SW; Yu J; Lee SK; Bae SY; Park S; Paik HJ; Lee JE
    Breast; 2016 Dec; 30():111-117. PubMed ID: 27697675
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy.
    Peiro G; Bornstein BA; Connolly JL; Gelman R; Hetelekidis S; Nixon AJ; Recht A; Silver B; Harris JR; Schnitt SJ
    Breast Cancer Res Treat; 2000 Jan; 59(1):49-54. PubMed ID: 10752679
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical value of adjuvant radiotherapy in patients with early stage breast cancer with 1 to 3 positive lymph nodes after mastectomy.
    Wu SG; He ZY; Li FY; Wang JJ; Guo J; Lin Q; Guan XX
    Chin J Cancer; 2010 Jul; 29(7):668-76. PubMed ID: 20591219
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of atypical hyperplasia at margins of breast-conserving surgery on the recurrence of breast cancer.
    Li S; Liu J; Yang Y; Zeng Y; Deng H; Jia H; Li Q; Feng H; Li Y; Song E; Liu Q; Su F
    J Cancer Res Clin Oncol; 2014 Apr; 140(4):599-605. PubMed ID: 24509653
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast recurrence and survival related to primary tumor location in patients undergoing conservative surgery and radiation for early-stage breast cancer.
    Fowble B; Solin LJ; Schultz DJ; Weiss MC
    Int J Radiat Oncol Biol Phys; 1992; 23(5):933-9. PubMed ID: 1322386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 69.